Katherine A. High
2016
In 2016, Katherine A. High earned a total compensation of $2.2M as President and Chief Scientific Officer at Spark Therapeutics, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $260,000 |
|---|---|
| Salary | $416,558 |
| Stock Awards | $1,456,637 |
| Other | $27,976 |
| Total | $2,161,171 |
High received $1.5M in stock awards, accounting for 67% of the total pay in 2016.
High also received $260K in non-equity incentive plan, $416.6K in salary and $28K in other compensation.
Rankings
In 2016, Katherine A. High's compensation ranked 4,539th out of 14,075 executives tracked by ExecPay. In other words, High earned more than 67.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,539 out of 14,075 | 68th |
Division Manufacturing | 1,611 out of 5,486 | 71st |
Major group Chemicals And Allied Products | 501 out of 1,900 | 74th |
Industry group Drugs | 370 out of 1,543 | 76th |
Industry Biological Products, Except Diagnostic Substances | 67 out of 287 | 77th |
Source: SEC filing on April 21, 2017.
High's colleagues
We found four more compensation records of executives who worked with Katherine A. High at Spark Therapeutics in 2016.